Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1995 2
2001 1
2004 1
2006 1
2010 3
2011 1
2013 3
2014 6
2015 1
2016 1
2017 4
2018 1
2019 1
2020 2
2021 2
2022 3
2023 2
2024 7
2025 15
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.
Liaki V, Barrambana S, Kostopoulou M, Lechuga CG, Zamorano-Dominguez E, Acosta D, Morales-Cacho L, Álvarez R, Sun P, Rosas-Perez B, Barrero R, Jiménez-Parrado S, López-García A, San Roman M, López-Gil JC, Drosten M, Sainz B Jr, Musteanu M, Caleiras E, Dusetti N, Poli V, Sánchez-Bueno F, Guerra C, Barbacid M. Liaki V, et al. Among authors: lechuga cg. Proc Natl Acad Sci U S A. 2025 Dec 9;122(49):e2523039122. doi: 10.1073/pnas.2523039122. Epub 2025 Dec 2. Proc Natl Acad Sci U S A. 2025. Retraction in: Proc Natl Acad Sci U S A. 2026 May 5;123(18):e2612385123. doi: 10.1073/pnas.2612385123. PMID: 41329731 Free PMC article. Retracted.
Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation.
García-Alonso S, Mesa P, Ovejero LP, Aizpurua G, Lechuga CG, Zarzuela E, Santiveri CM, Sanclemente M, Muñoz J, Musteanu M, Campos-Olivas R, Martínez-Torrecuadrada J, Barbacid M, Montoya G. García-Alonso S, et al. Among authors: lechuga cg. Mol Cell. 2022 Sep 15;82(18):3438-3452.e8. doi: 10.1016/j.molcel.2022.08.012. Epub 2022 Sep 1. Mol Cell. 2022. PMID: 36055235 Free article.
Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas.
Salmón M, Álvarez-Díaz R, Fustero-Torre C, Brehey O, Lechuga CG, Sanclemente M, Fernández-García F, López-García A, Martín-Guijarro MC, Rodríguez-Perales S, Bousquet-Mur E, Morales-Cacho L, Mulero F, Al-Shahrour F, Martínez L, Domínguez O, Caleiras E, Ortega S, Guerra C, Musteanu M, Drosten M, Barbacid M. Salmón M, et al. Among authors: lechuga cg. J Clin Invest. 2023 Apr 3;133(7):e164413. doi: 10.1172/JCI164413. J Clin Invest. 2023. PMID: 36928090 Free PMC article.
Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors.
Fernández-García F, Fernández-Rodríguez A, Fustero-Torre C, Piñeiro-Yáñez E, Wang H, Lechuga CG, Callejas S, Álvarez R, López-García A, Esteban-Burgos L, Salmón M, San Román M, Guerra C, Ambrogio C, Drosten M, Santamaría D, Al-Shahrour F, Dopazo A, Barbacid M, Musteanu M. Fernández-García F, et al. Among authors: lechuga cg. Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2402913121. doi: 10.1073/pnas.2402913121. Epub 2024 Aug 26. Proc Natl Acad Sci U S A. 2024. PMID: 39186651 Free PMC article.
Ras in epidermal proliferation.
Drosten M, Lechuga CG, Barbacid M. Drosten M, et al. Among authors: lechuga cg. Oncotarget. 2014 Jul 30;5(14):5194-5. doi: 10.18632/oncotarget.2275. Oncotarget. 2014. PMID: 25114036 Free PMC article. No abstract available.
The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutations.
Ballesteros-González I, Hernández-Navas I, Brehey O, Lechuga CG, Salmón M, Scotece M, Velasco-Vicente R, Flores-Gómez AA, Cebriá A, Simón-Carrasco L, Jiménez G, Musteanu M, Guerra C, Domínguez O, Caleiras E, Blanco-Aparicio C, Pons T, Ferrer I, Paz-Ares L, Torres-Ruiz R, Rodríguez-Perales S, Barbacid M, Drosten M. Ballesteros-González I, et al. Among authors: lechuga cg. EMBO Mol Med. 2025 Dec;17(12):3377-3406. doi: 10.1038/s44321-025-00326-z. Epub 2025 Nov 11. EMBO Mol Med. 2025. PMID: 41219537 Free PMC article.
PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity.
Martínez-Bosch N, Manero-Rupérez N, Vázquez-Bellón N, Nickell-Hernández B, Ventura-Blanch C, Lutfi N, Lechuga CG, Martínez C, Moreno M, Ampurdanés C, Abad E, Iglesias M, Muñoz-Escribano M, Janic A, Rovira M, Guerra C, Rabinovich GA, Yélamos J, Navarro P. Martínez-Bosch N, et al. Among authors: lechuga cg. Sci Adv. 2026 May 8;12(19):eadu8849. doi: 10.1126/sciadv.adu8849. Epub 2026 May 8. Sci Adv. 2026. PMID: 42102213 Free PMC article.
Multimodal Characterization of High-risk PH-HFpEF phenogroup with Right Ventricular Dysfunction: Vascular Mechanics and Myocardial Transcriptomics.
Raza F, Gregorich ZR, Freeman J, Houston T, Garcia-Arango M, Lechuga C, Chen Y, Sahai A, Shaer AE, Korcarz C, Cui K, Park Y, Jones K, Tu W, Runo J, Schulte JJ, Nagpal P, Ge Y, Chesler N, Stewart R, Wieben O, Guo W. Raza F, et al. Among authors: lechuga c. medRxiv [Preprint]. 2025 May 16:2025.05.15.25327467. doi: 10.1101/2025.05.15.25327467. medRxiv. 2025. PMID: 40463546 Free PMC article. Preprint.
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue.
Díaz-Alejo JF, April-Monn S, Cihova M, Buocikova V, Villalón López J, Urbanova M, Lechuga CG, Tomas M, Dubovan P, Sánchez BL, Páez SC, Sanjuanbenito A, Lobo E, Romio de la Heras E, Guerra C, de la Pinta C, Barreto Melian E, Rodríguez Garrote M, Carrato A, Ruiz-Cañas L, Sainz B Jr, Torres A, Smolkova B, Earl J. Díaz-Alejo JF, et al. Among authors: lechuga cg. J Vis Exp. 2023 May 26;(195). doi: 10.3791/65229. J Vis Exp. 2023. PMID: 37306424
60 results